Satellos Bioscience Inc. granted patent
- U.S. Patent No. 12,747,245 issued on 2026-10-05
- Patent covers forazapadin and AAK1 inhibitors
- Protection lasts until Sept. 6, 2044
Every EDGAR filing for Satellos Bioscience Inc. (MSCLD), newest first, with AI summaries and stories.
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Ownership stake disclosure by Brian Matthew Bloom
Brian Matthew Bloom, filed by
Ownership stake disclosure by Qiming U.S. Healthcare Fund III, L.P.
Qiming U.S. Healthcare Fund III, L.P., filed by